• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,312.17 570.35
( 0.74%)
Global Indices
Nasdaq
52,499.17 129.78
(0.25%)
Dow Jones
7,562.80 59.09
(0.79%)
Hang Seng
67,966.49 1,147.44
(1.72%)
Nikkei 225
10,472.08 -16.96
(-0.16%)
Forex
USD-INR
95.15 -0.21
(-0.22%)
EUR-INR
108.73 -0.26
(-0.24%)
GBP-INR
127.27 -0.11
(-0.09%)
JPY-INR
0.59 0.00
(-0.14%)

EQUITY - MARKET SCREENER

Alkem Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
539523
INE540L01014
1170.8077615
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ALKEM
29.31
67529.71
EPS(TTM)
Face Value()
Div & Yield %
192.67
2
0.94
 

Excel Industries consolidated net profit declines 1.05% in the March 2026 quarter
May 23,2026
Net profit of Excel Industries declined 1.05% to Rs 12.28 crore in the quarter ended March 2026 as against Rs 12.41 crore during the previous quarter ended March 2025. Sales rose 13.48% to Rs 281.24 crore in the quarter ended March 2026 as against Rs 247.84 crore during the previous quarter ended March 2025.

For the full year,net profit declined 11.30% to Rs 75.67 crore in the year ended March 2026 as against Rs 85.31 crore during the previous year ended March 2025. Sales rose 11.91% to Rs 1094.52 crore in the year ended March 2026 as against Rs 978.07 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales281.24247.84 13 1094.52978.07 12
OPM %7.827.90 -10.0412.18 -
PBDT24.3025.05 -3 134.70147.01 -8
PBT14.6616.29 -10 97.80112.94 -13
NP12.2812.41 -1 75.6785.31 -11